Inserm Transfert
Created in 2000
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
653 7,318Entity types
Location
Jardin Biopark, 11 Rue Watt, 75013 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 120
SIREN
434033619Engaged corporates
74
29 56Added in Motherbase
3 years, 1 month ago
Incubators & VCs Value proposition
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Knowledge Transfer, R&D, Licensing, Partnerships, European & International Research Projetcs, Public Health, techtransfert, valorisation, lifescience, and biotechnologyOriginal language
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Inserm Transfert - Accueil
Inserm Transfert, fondée en 2000, est la filiale privée de l’Inserm spécialisée dans le transfert de technologies en sciences de la vie
https://www.inserm-transfert.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 16 Nov 2022 8 Oct 2024 | | |
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 12 Feb 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Feb 2022 16 May 2023 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 5 Oct 2020 1 Oct 2024 | | |